B., & Yue, K
The initial rating for RCTs was high and decreased in presence of serious inconsistency, indirectness, imprecision, risk of bias, or when publication bias was likely
Mt s ngi c th gp tc dng ph nh nh chut rt, d ng hoc kh th nhng rt him gp
This contraindication applies to semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide extended-release (Bydureon BCise), tirzepatide (Mounjaro, Zepbound), and the combination product Xultophy (insulin degludec/liraglutide)
The action of free radicals may interfere with the growth of tissues, change the metabolism and functioning of cells, destroy lipid and protein structures
Wang L, Li S, Fan H, Han M, Xie J, Du J, Peng F